Press release
Breast Cancer Diagnostic and Drug Technologies Market : Global Snapshot Analysis 2018-2022
Currently, there are about REDACTED million women living with cancer, globally, and the incidence is gradually increasing. In women, breast cancer is the second leading cause of cancer death. Per World Health Organization (WHO) statistics, about one-third of these cancer fatalities can be decreased through earlier detection and treatment. Early breast cancer treatment and detection have improved the five-year survival rate for women diagnosed with cancer to nearly 80%. The breast cancer diagnostic and drug technology markets include a variety of products approved for breast cancer treatment, including hormonal therapies, chemotherapeutic drugs, combinations and targeted therapies. Many side effects, adverse reactions and safety concerns have come up associated with newer, innovative drugs. Therefore, drugs with improved safety and efficacy are needed to treat breast cancer effectively.
Download a PDF Sample of this Report @ http://orbisresearch.com/contacts/request-sample/2132202?utm_source=sd
In countries such as the United States, the chance of a woman developing breast cancer during her lifetime has increased. An estimated 522,000 women died from breast cancer globally in the year 2012. WHO estimates that more than REDACTED million new cancer cases will be diagnosed by 2030. Rising healthcare costs associated with breast cancer treatment, have left several patients either uninsured or with less meaningful coverage than they need and deserve.
With the anticipated increase in the number of breast cancer cases, breast cancer research and development is attractive and requires attention from pharmaceutical firms. Drugs for breast cancer comprise a dynamic and growing global market. The market for breast cancer drugs is predicted to reach REDACTED billion by 2022, with Roche predicted to account for more than half of the market. Common detection techniques for breast cancer are diagnostic mammography and ultrasound followed by biopsy. Studies clearly show that breast cancer treatment is far more effective when cancer is detected at an early stage. Therefore, specific and effective diagnostic tools are needed for early diagnosis.
Enquiry before buying report @ http://orbisresearch.com/contacts/enquiry-before-buying/2132202?utm_source=sd
Reasons for Doing This Study
There has been a significant improvement in understanding the molecular and cellular mechanism of cancer metastasis. As incidence of breast cancer is increasing globally, government agencies and research firms are focused on developing new diagnostics, predictive diagnostics and predictive tools to identify breast cancer in early stages where patient survival is increased. Several targeted therapies have evolved over the last decades and several others are likely to reach the market in the next five years. Due to increased investment, raising cancer awareness and research and development activities the breast cancer diagnostic and therapy market dynamics are expected to change during the forecast period. The intent of this study is to provide readers with detailed information regarding the latest innovative developments for early identification of breast cancer and targeted therapy. This study looks at different classes of available drug types and their applications. This report also identifies potential pipeline molecules which could translate into clinical practice.
Report Scope:
This report is an update to Breast Cancer Diagnostics and Therapeutics Market Report-HLC106B.
The objective of the current report is to provide the readers with updated market estimates for the diagnostics and therapeutics market. This report also highlights current and future market potential for breast cancer therapeutics along with a detailed analysis of the competitive environment, pipeline drugs, blockbuster drugs and other diagnostic and therapeutic development.
The report includes breast cancer epidemiology including global and regional prevalence, incidence and mortality rates; regulatory environment for markers and therapeutics along with recent regulatory approvals, current and new technologies, market projections and market share for key market players. Market drivers, trends and potential regional market opportunities for diagnostics and therapeutics are also identified in this report.
The report details currently available diagnostic breast cancer screening tests, breast cancer staging and prognostic technology advancements, predictive diagnostic tests and the latest therapy developments for breast cancer treatment. This study evaluates available tumor marker-based predictive companion tests and FDA approved drugs for treating breast cancer. Screening biomarkers, pipeline analysis, patent analysis and reimbursement scenarios are some additions to the current report.
This report includes market estimates for breast cancer diagnostics (mammography, biopsy and companion diagnostics), therapeutics along with market share of therapeutics by drug class (HER2 inhibitors, mitotic inhibitors, anti-metabolites, aromatase inhibitors and hormone receptors), geographic market segmentation of the overall market and global market share by company with special emphasis on developed and underdeveloped geographic regions. For market estimates, data has been provided for the year 2016, as the base year, 2017 and a forecast for 2022.
Access the complete report with TOC & List of Tables @ http://orbisresearch.com/reports/index/breast-cancer-diagnostic-and-drug-technologies-global-markets?utm_source=sd
Report Includes:
- 36 data tables and 47 additional tables
- Country specific data and analysis for United States, Canada, Mexico, UK, France, Germany, Italy, China, India, Japan, and South Korea
- Estimated revenue of the global mammography, biopsy, companion diagnostic IVD, and therapeutic markets by various segments and subsegments
- Identification of key market dynamics, trends, and opportunities
- Insight into mergers and acquisitions, new product developments, strategies, and research-and-development activities
- Comprehensive profiles of major players in the market, including Abbvie, Inc., Abbott Laboratories, Bristol-Myers Squibb Company, Dako, Eli Lilly and Company, Novartis International AG, and Pfizer, Inc.
Companies Mentioned:
ABBOTT LABORATORIES
ABBVIE INC.
ASTRAZENECA PLC
ATOSSA GENETICS INC.
BRISTOL-MYERS SQUIBB COMPANY
CCC DIAGNOSTICS LLC
DAKO
ELI LILLY AND COMPANY
F. Hoffmann-La Roche AG
NANOSTRING TECHNOLOGIES
NOVARTIS INTERNATIONAL AG
PFIZER, INC.
PUMA BIOTECHNOLOGY INC.
SANOFI S.A.
Table of Content
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Introduction
Classification of Breast Cancer by Type
Non-invasive Breast Cancers
Ductal Carcinoma Insitu (DCIS)
Lobular Carcinoma Insitu (LCIS)
Invasive Breast Cancers
Invasive (or Infiltrating) Ductal Carcinoma (IDC)
Invasive (or Infiltrating) Lobular Carcinoma (ILC)
Tubular Carcinoma (TC)
Invasive Cribriform Carcinoma
Mucinous Carcinoma
Invasive Papillary Carcinoma
Inflammatory Breast Cancer
Paget's Disease of the Breast
Cytosarcoma Phyllodes
Metastatic Breast Cancer (MBC)
Molecular Subtypes of Breast Cancer
Luminal A
Luminal B Types
HER2 Type
HER2-Amplified
Triple-Negative Breast Cancer (TNBC) or Basal Type
Normal-Like
Causes, Indications and Risk Factors
Symptoms
Breast Cancer Staging
Epidemiology
United States Breast Cancer Incidence
Chapter 4 Breast Cancer Market Dynamics
Market Drivers
Increasing Incidence of Breast Cancer Worldwide
Focused Research and Development for Novel Drugs
High Increase in Healthcare Expenditure and Funding
Increasing Breast Cancer Screening Programs
Favorable Reimbursement for Screening and Diagnosis
Market Restraints
Pricing Pressure Experienced by Innovators
High Cost Associated with New Drug Development and Clinical Trials
Regulatory and Reimbursement Hurdles
Market Opportunity
Rising Female Population in Asia Pacific
Increased Demand for Technology Innovation
Technological Advancement in the Drug Sector
Emergence of Breast Cancer Predictive Tests
Opportunity for Generic Manufacturers to Exploit Patents at the Verge of Expiry
Breast Cancer Therapy: Unmet Needs
Chapter 5 Market Breakdown by Technology
Breast Cancer Diagnostic Market
Mammography
Latest Developments
Mammography Procedure Volumes
Global Mammography Market
Limitations of Mammography
Breast Biopsy Device Market
Introduction
Global Breast Biopsy Device Market
Breast Cancer Predictive Diagnostic Market
Introduction
Predictive Diagnostic Tests
Global Breast Cancer Companion Diagnostic Test Market
Chapter 6 Market Breakdown by Drug Class
Overview
Breast Cancers Drug Classes
Breast Cancer Market
Antimetabolites
Tanaxanes
Aromatase Inhibitors
HER2 Inhibitor
Hormone Therapy
Chapter 7 Market Breakdown by Region
Breast Cancer Incidence by Region
Global Market by Region
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America
Chapter 8 Regulatory Scenario
Breast Cancer Diagnostics and Therapeutics Regulatory Challenges
North America
Food and Drug Administration (FDA)
Europe
Asia-Pacific
Japan
China
South America
Brazil
Chapter 9 Patent Review/New Developments
Patent Review
Companion Diagnostics
Patent Expiration
Chapter 10 Reimbursement Landscape
Introduction
United States
Mammography Procedure Reimbursement
Biopsy Procedure Reimbursement
Breast Cancer Drugs Reimbursement
Germany
Mammography Procedure Reimbursement
Biopsy Procedure Reimbursement
Breast Cancer Drugs Reimbursement
Mexico
Brazil
Chapter 11 Pipeline Analysis
Introduction
Breast Cancer Therapeutics Pipeline by Phases
Phase III
Phase II
Phase I
Breast Cancer Therapeutics Pipeline by Company
AbbVie, Inc.
Array BioPharma, Inc.
AstraZeneca
Belrose Pharmaceuticals
Beta Pharma
BioMarin Pharmaceuticals
CASI Pharmaceuticals, Inc.
Celgene
Celldex Therapeutics
Celsion
Clovis
Clovis Eli Lilly
Novartis
Pfizer
Puma Biotechnology
Roche
Syndax Pharmaceuticals
Tesaro Inc.
Chapter 12 Competitive Landscape
Major Mammography Equipment Market Players
Major Breast Cancer Drug Market Players
Chapter 13 Company Profiles
ABBVIE INC.
Company Overview
Financials
Products
Developments and Strategies
ABBOTT LABORATORIES
Company Overview
Financials
Product Information
Development and Strategies
ASTRAZENECA PLC
Company Overview
Financials
Product Information
Development and Strategy
ATOSSA GENETICS INC.
Overview
Financials
Products
Developments and Strategies
BRISTOL-MYERS SQUIBB COMPANY
Company Overview
Financials
Product Information
Development and Strategies
CCC DIAGNOSTICS LLC
Company Overview
Product Information
DAKO
Company Overview
Product Information
ELI LILLY AND COMPANY
Company Overview
Financials
F. HOFFMANN-LA ROCHE AG
Company Overview
NANOSTRING TECHNOLOGIES
Company Overview
NOVARTIS INTERNATIONAL AG
Company Overview
PFIZER, INC.
Company Overview
Financials
PUMA BIOTECHNOLOGY INC.
Company Overview
Financials
Product Information
Development and Strategies
SANOFI S.A.
Overview
Financials
Development and Strategies
Chapter 14 Abbreviations
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Cancer Diagnostic and Drug Technologies Market : Global Snapshot Analysis 2018-2022 here
News-ID: 1064118 • Views: …
More Releases from Orbis Research
Blood Purification Devices Market 2023-2028 | Top Players Baxter International, …
Based on the type segment, the portable equipment segment is expected to hold the largest share in Blood Purification Devices in the year 2028. Professionals that are actively involved in the ongoing purification of blood tend to favour portable equipment. Equipment that is portable enables effective emergency care. Additionally, portable equipment is rather space-efficient and compact, which promotes widespread use throughout the blood-purification process. In a manner similar to how…
Clean Beauty Market to Grow at 40.1% CAGR by 2028 - Key Players are Bare Mineral …
Clean beauty is described as beauty and personal care products that are made with the safest possible ingredients and have the lowest possible environmental impacts. Clean beauty pertains to products that are safe, non-toxic, and clearly labelled ingredients Also, the ingredients used are cruelty-free and are screened for non-GMO feedstock and residual pesticides.
Request a pdf brochure @ https://www.orbisresearch.com/contacts/request-sample/6941781
The Clean Beauty Market is valued at USD 5163.17 Million in 2021 and…
Outdoor Power Equipment Market Worth USD 6.49 Bn by 2027 - Industry Trends and S …
The outdoor power equipment generally includes, brush cutters, edger, chain saws, power rakes, and more. Outdoor power equipment is commonly used by end users, such as lawn & plant care providers and landscape service providers, for commercial purposes.
The global outdoor power equipment market in 2021 was valued at US$32.22 billion. The market value is projected to reach US$46.49 billion by 2027. Outdoor power equipment (OPE) is an equipment with small…
Merchant API Market to reach US$119.11 billion by 2027 - Industry Trends, Growth …
The latest research on "Global Merchant API Market: Analysis By Molecular Type, By Segment, By Type, By Type of Synthesis, By End-User, By Region Size And Trends With Impact Of COVID-19 And Forecast up to 2027" have been added to OrbisResearch.com store.
The merchant API market refers to the use of APIs by merchants, or businesses that sell goods and services, to connect their systems and processes with those of other…
More Releases for Breast
Breast Health Monitoring App Market to Witness a Pronounce Growth during 2024-20 …
The latest market intelligence report published by WMR with the title "Global Breast Health Monitoring App Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Healthcare and Pharmaceuticals industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.
The Research report on Breast Health Monitoring App Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y…
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer …
FOR IMMEDIATE RELEASE
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer During Breast Cancer Awareness Month
Liverpool, UK - October, 2023 - Phil Alderson, a primary survivor of male breast cancer, is taking bold steps this Breast Cancer Awareness Month to raise awareness of this often overlooked aspect of the disease. With a homemade cardboard sign that reads "Check Your Pecks," Phil has taken to the streets of…
Breast Health Monitoring App Market Recent Trends, In-depth Analysis, Size, and …
According to The Worldwide Market Reports, the Latest research report on "Breast Health Monitoring App Market Size, Revenue, Global Analysis, and Forecast 2023 to 2030" The Breast Health Monitoring App Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore,…
Breast Pumps Market - Nurturing Convenience: Revolutionizing Breast Pump Technol …
Newark, New Castle, USA - new report, titled Breast Pumps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Breast Pumps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Breast Pumps market. The report offers an overview of the market, which…
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues.
Download Free PDF Brochure on Brest Imaging Market Report Now…
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to…
